Skip to main content

Table 3 Reversion and non-reversion of QFT-IT among ESRD patients with 1st QFT-IT positive result

From: Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population

ESRD patients (N = 39)

Reversion

Non-reversion

OR (95 % CI)

P value

Dialysis method

     
 

PD

7 (35.0 %)

13 (65.0 %)

9.7 (1.1–88.7)

0.04

 

HD

1 (5.3 %)

18 (94.7 %)

1 (Ref.)

 

Treatment

     
 

LTBI treatment

5 (27.8 %)

13 (72.2 %)

2.3 (0.5–11.4)

0.43

 

No LTBI Treatment

3 (14.3 %)

18 (85.7 %)

1 (Ref.)

 

Treatment drug

     
 

Rifampin

3 (37.5 %)

5 (62.5 %)

2.4 (0.3–19.8)

0.61

 

INH

2 (20.0 %)

8 (80.0 %)

1 (Ref.)

 
  1. OR odds ratio, PD peritoneal dialysis, HD hemodialysis, LTBI latent tuberculosis infection, RFP rifampicin, INH isoniazid
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us